The Fight for Transparency

lterrat's bookmarks 2016-11-22

Summary:

"Ben Goldacre’s 'Bad Pharma' propelled the issue of clinical trial transparency into public discourse when it was published in September 2012. The European Medicines Agency (EMA) responded quickly – discussing both the practical and policy issues surrounding clinical data transparency as early as November that same year. Since then, the EMA has continued to develop its open access policy though consultations with the public and various stakeholders, resulting in the agency’s policy of proactively releasing clinical study reports. the EMA released guidance around the publication of clinical data earlier this year (1)."

Link:

https://themedicinemaker.com/issues/0916/the-fight-for-transparency/

From feeds:

Open Access Tracking Project (OATP) » lterrat's bookmarks

Tags:

Date tagged:

11/22/2016, 18:50

Date published:

11/22/2016, 13:50